Crenigacestat (LY3039478) is an orally bioavailable Notch inhibitor with an IC50 of ~1 nM in most tumor cell lines tested. It effectively inhibits mutant Notch receptor activity and, in a xenograft tumor model, inhibits the expression of Notch-regulated genes and N1ICD cleavage in the tumor microenvironment.
Molecular Weight:
464.44
Purity:
97.27%
CAS Number:
[1421438-81-4]
Formula:
C22H23F3N4O4
Target:
Gamma-secretase
T3633
* VAT and and shipping costs not included. Errors and price changes excepted